Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
about
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisDeveloping psychosis and its risk states through the lens of schizotypy.North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal SymptomsEmotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder.Glutamate-mediated excitotoxicity in schizophrenia: a review.Brain change trajectories that differentiate the major psychoses.Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.Performance of joint modelling of time-to-event data with time-dependent predictors: an assessment based on transition to psychosis data.The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A ReviewErythrocyte glutathione levels as long-term predictor of transition to psychosisA critique of the "ultra-high risk" and "transition" paradigm.Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk stateCurrent status specifiers for patients at clinical high risk for psychosis.Reduction in incidence of hospitalizations for psychotic episodes through early identification and intervention.Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.Trauma history characteristics associated with mental states at clinical high risk for psychosis.Self-Disorders and Clinical High Risk for Psychosis: An Empirical Study in Help-Seeking Youth Attending Community Mental Health FacilitiesClinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.Substance use in people at clinical high-risk for psychosis.Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence.Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.Psychosis risk syndrome is not prodromal psychosis.Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersSpecificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing.EEG-Informed fMRI Reveals a Disturbed Gamma-Band-Specific Network in Subjects at High Risk for PsychosisSeverity of thought disorder predicts psychosis in persons at clinical high-risk.Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.Demographic correlates of attenuated positive psychotic symptomsProgress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Emotional Experiences Predict the Conversion of Individuals with Attenuated Psychosis Syndrome to Psychosis: A 6-Month Follow up Study.Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program.Ultra high risk status and transition to psychosis in 22q11.2 deletion syndromePrediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.
P2860
Q26748778-2A7D6172-5931-41BD-AA6E-ACF59BB7A12AQ26822553-A456E3CD-EC75-43B9-92BE-DE76DA9001DFQ27011767-E65F086E-FA94-489C-B2D2-A4D163183ABDQ30371792-DDBCE340-DBB6-491B-9F1C-7D2C6359C067Q30604468-16A8490C-D200-48F8-BA58-A5E30F1EBD84Q30845062-A818D4CA-E02E-470A-882A-67D7BF8EC07DQ31099010-6BF9B5A1-6447-4EFC-937D-E0DF668EA5C8Q31122156-EF2186EE-B980-4AD5-A445-41C52C09FD7DQ31139079-D0A1A6E7-FFEB-4724-B398-345992FF10A5Q33581212-2890BA48-9AC2-4114-81C2-C26A9E2EAF0EQ33635566-2657D20F-A608-4468-A7A2-41502DBAD9BDQ33670654-71FCBA89-8754-4A6C-A57E-7D7780AAF5B4Q33814290-27E7B770-494A-4E27-802C-F8B441F03DC9Q33817901-35C9D109-10B2-455E-8123-54263FBF608DQ34123531-94B72717-5BBE-4A57-9896-6E0D9A3D111DQ34203122-0377DF5D-1899-4398-B4E7-9BDE54EC9BB5Q34270086-A13041C0-F7E6-43C8-8C76-37592B2398BDQ34322953-B0ACBAE5-E87F-447D-BEED-96CF8237741AQ34446370-7FE966C9-7D15-4400-9099-7760A28EB7DEQ34508665-9F712FA8-4E76-434D-A6A3-DCBD9506176AQ34701054-65ADB6A6-1315-462A-8458-E18573F5BF7DQ34987780-003A23D3-6094-481A-A3EC-182D673E26B0Q35006376-CCE948C4-FC4F-41A4-9268-D6CABE8D6C9AQ35034786-58E41B71-D4CA-47D2-B5D8-4EA3EB4E2497Q35096522-1648EC0C-93CA-4C89-A1C1-E8C2AEF07A2EQ35214828-5C8844BF-19E1-4AC1-8A5A-81B60C9CB188Q35621468-DEFCD443-8CEE-4CDB-BF9E-3BB7F2F705DCQ35950862-FA87CD79-7836-413F-ABE5-E96701386DA8Q36102040-0C0B8371-2434-460E-BF2D-94746C2D2C0CQ36221808-978FC291-EA80-412B-B8C7-52FA2BE14FBDQ36377868-C06784D8-ED6F-459A-B736-2103F9944962Q36377966-9C79D0E3-9E47-4F5E-AAED-DDFC04D70680Q36378238-C621CC05-E8AC-476B-9130-37824544911AQ36617938-A90F4A7C-C28A-4315-A087-41CCB7D4F51AQ36910682-6C4C7F1A-83A3-4255-A4DF-8AF789B2581CQ36955474-336B71DD-E8ED-4E8A-A78E-8A3F5A135C0FQ37031821-5D05938A-B032-4DEE-B898-74A0FA1AD64BQ37194050-D972F455-8B28-47CC-A828-468EC5F022B6Q37274686-D93FAF05-5B9D-455C-8971-6D536C04A12DQ37307208-15C78D45-07B5-4054-8FC0-69D009368639
P2860
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Long-term follow-up of a group ...... psychosis: the PACE 400 study.
@en
Long-term follow-up of a group at ultra high risk
@nl
type
label
Long-term follow-up of a group ...... psychosis: the PACE 400 study.
@en
Long-term follow-up of a group at ultra high risk
@nl
prefLabel
Long-term follow-up of a group ...... psychosis: the PACE 400 study.
@en
Long-term follow-up of a group at ultra high risk
@nl
P2093
P50
P1433
P1476
Long-term follow-up of a group ...... psychosis: the PACE 400 study.
@en
P2093
Annie Bruxner
Ashleigh Lin
Barnaby Nelson
Christina Broussard
Daniela Spiliotacopoulos
Debra L Foley
G Paul Amminger
Hok Pan Yuen
Magenta Simmons
Patrick D McGorry
P304
P356
10.1001/JAMAPSYCHIATRY.2013.1270
P407
P577
2013-08-01T00:00:00Z